A randomised, controlled, multidose, multicentre, adaptive phase II/III study in infants with proliferating infantile hemangiomas requiring systemic therapy to compare four regimens of propranolol (1 or 3 mg/kg/day for 3 or 6 months) to placebo (double blind).
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy.
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement - ONICO
100 项与 Pierre Fabre Dermatologie SAS 相关的临床结果
0 项与 Pierre Fabre Dermatologie SAS 相关的专利(医药)
100 项与 Pierre Fabre Dermatologie SAS 相关的药物交易
100 项与 Pierre Fabre Dermatologie SAS 相关的转化医学